Cited by 647Multiple Sclerosis Research StudiesNeurogenesis and neuroplasticity mechanismsMesenchymal stem cell research

Regenerating CNS myelin — from mechanisms to experimental medicines

Open access
Franklin, Robin J. M., ffrench-Constant, Charles·2017·Nature Reviews Neuroscience

Abstract

Although the core concept of remyelination - based on the activation, migration, proliferation and differentiation of CNS progenitors - has not changed over the past 20 years, our understanding of the detailed mechanisms that underlie this process has developed considerably. We can now decorate the central events of remyelination with a host of pathways, molecules, mediators and cells, revealing a complex and precisely orchestrated process. These advances have led to recent drug-based and cell-based clinical trials for myelin diseases and have opened up hitherto unrecognized opportunities for drug-based approaches to therapeutically enhance remyelination.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/nrn.2017.136

Cites

221 of 221 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Efficient myelin debris removal and clearance by phagocytic cells are critical to eliminate inhibitory signals interfering with OPC activation, recruitment to the site of demyelination and/or differentiation into myelinating mature oligodendrocytes.

    “Efficient myelin debris removal and clearance by phagocytic cells are critical to eliminate inhibitory signals interfering with OPC activation, recruitment to the site of demyelination and/or differentiation into myelinating mature OLs [14, 26, 27].”

    From TREM2 activation on microglia promotes myelin debris clearance and remyelination in a model of multiple sclerosis (2020) · cites this paper as [14]

    In “Systemic factors and remyelination” (page not available), the review says phagocytic macrophages clear myelin debris containing inhibitors of OPC differentiation, and that clearance prevents interference with the final stage of remyelination. It does not say that those debris-borne inhibitors interfere with OPC activation or recruitment; its discussion of macrophages during recruitment concerns a different role. (LLM, conf=0.88)

    Experimental — accuracy not yet measured
  • CNS remyelination fails in prevalent neurodegenerative disorders, contributing to axon dysfunction/loss.

    “Central nervous system (CNS) remyelination reinstates axon health/ function1, yet fails in prevalent neurodegenerative disorders contributing to axon dysfunction/loss for which there is an unmet therapeutic need.”

    From Central nervous system regeneration is driven by microglia necroptosis and repopulation (2019) · cites this paper as [1]

    The introductory passage (indexed under “Author biographies”; page unavailable) says remyelination ultimately fails for many patients with multiple sclerosis and that loss of myelin’s metabolic support is thought to contribute to axonal degeneration. “Why is remyelination important?” cautions that the observed association does not establish causality. The source does not establish remyelination failure across prevalent neurodegenerative disorders generally. (LLM, conf=0.88)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

1 of the 222 references couldn’t be matched to a known paper.

Research works printed but not linked: 1

  1. Lucchinetti, C. et al. Heterogeneity of multiple sclerosis lesions: implications for the pathogenesis of demyelination. Ann. Neurol. 47, 707–717 (2000). · DOI

Cited by

Sorted by citations

Authors
Franklin, R. J. M., & ffrench-Constant, C.
Affiliations
Wellcome/MRC Cambridge Stem Cell Institute (GB)
Corresponding author
Franklin, Robin J. M.
Venue
Nature Reviews Neuroscience
Published
2017-11-16
Volume
18
Issue
12
Pages
753-769
ISSN
  • 1471-003X (ISSN-L)
  • 1471-0048
OpenAlex
W2770653478
Cited by
647
References
222
Citations by year
2026: 84 · 2025: 72 · 2024: 84 · 2023: 58 · 2022: 83 · 2021: 83 · 2020: 70 · 2019: 79 · 2018: 33 · 2017: 1
FWCI
7.99
Type
journal article
Language
en
Open access
Locations
  • Nature reviews. Neuroscience (publishedVersion)
  • PubMed (publishedVersion)
  • UEA Digital Repository (University of East Anglia) (submittedVersion)
  • Apollo (University of Cambridge) (submittedVersion)
  • Apollo
Funders
  • Wellcome Trust (104783/Z/14/Z)
  • Medical Research Council (MC_PC_12009)
Topics
  • Health Sciences › Medicine › Pathology and Forensic Medicine › Multiple Sclerosis Research Studies
  • Life Sciences › Neuroscience › Developmental Neuroscience › Neurogenesis and neuroplasticity mechanisms
  • Health Sciences › Medicine › Genetics › Mesenchymal stem cell research
Keywords
remyelination, central nervous system myelin, multiple sclerosis, demyelination, oligodendrocyte precursor cells, cell therapy, myelin diseases
MeSH terms
Animals, Cell Differentiation, Central Nervous System, Demyelinating Diseases, Humans, Myelin Sheath, Nerve Regeneration, Oligodendroglia

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review